Ivantis, Inc. designed and manufactured the Hydrus Microstent, a device used in glaucoma surgery to lower eye pressure. The Hydrus Microstent is a minimally invasive glaucoma surgery (MIGS) device designed to reduce reliance on glaucoma eye drops.
It’s important to understand Ivantis because its products are intended to offer a potentially less invasive way to manage glaucoma, a leading cause of blindness worldwide.
This article will cover what the Hydrus Microstent is, how it works, and recent news about Ivantis, including its acquisition by another company.